ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Ossification, Heterotopic

  • A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.
  • A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
  • Tranexamic Acid Prophylaxis for Heterotopic Ossification in Elbow Fracture-Dislocation Surgery
  • Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)
  • An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in People With Fibrodysplasia Ossificans Progressiva (FOP) in France
  • Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma
  • Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification
  • Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy
  • Prevention of Heterotopic Ossification With Arcoxia After Total Hip Replacement
  • Naproxen for the Prevention of HO After Complex Elbow Trauma
  • Study of Pamidronate for the Prevention of Heterotopic Ossification
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group